SO ERIC H. L. (Executive Chair) received a stock award from HELUS PHARMA INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/2/2026ACC: 0000912282-26-001335
DirectorOfficer· Executive Chair
Since Sep 2026
+248K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
248K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+248K
Price / share
—
Trade value
—
% of position
5.6%
9/30/2026
4.47M→4.71M
Total
Net shares
+248K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/30/2026 | A · Award | +248K | — | — | 5.6% | 4.47M | 4.71M |
| Total | +248K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned53.62K
Total
53.62K indirect53.62K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 53.62K | Indirect |
| Total | 53.62K | 53.62K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported